6 min listen
Cardiac Amyloidosis and the V142I Transthyretin Variant
Cardiac Amyloidosis and the V142I Transthyretin Variant
ratings:
Length:
13 minutes
Released:
May 12, 2024
Format:
Podcast episode
Description
What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women’s Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content: Cardiovascular Burden of the V142I Transthyretin Variant Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger Heart Failure in African American Individuals, Version 2.0 Cardiac Amyloidosis Due to Transthyretin Protein
Released:
May 12, 2024
Format:
Podcast episode
Titles in the series (100)
Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents: Interview with Frederick P. Rivara, MD, MPH, author of Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents by JAMA Author Interviews